---

Christopher Bolden, PhD

Assistant Professor of Cancer Biology, Louisiana Cancer Center, Xavier University of Louisiana

PIs: Matthew Lazzara

---

Initiative Two - 2025: Evaluating SorLA as a Therapeutic Target in Glioblastoma Using a 3D In Vitro BBB System